ELV vs UNH
ELV and UNH side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ELVELEVANCE HEALTH, INC. | UNHUnitedHealth Group Incorporated |
|---|---|---|
| Market cap | $85.49B | $369.70B |
| P/E (TTM) | 17.4 | 30.7 |
| P/B | 1.90 | 11.20 |
| P/S | 0.4x | 0.8x |
| Dividend yield | 1.79% | 2.14% |
| Revenue | $201.11B(TTM) | $449.71B(TTM) |
| Revenue growth (YoY) | 12.5% | 11.8% |
| Net income | $4.96B(TTM) | $12.04B(TTM) |
| Earnings growth (YoY) | -5.3% | -16.3% |
| EPS, diluted | $22.61(TTM) | $13.28(TTM) |
| EBIT margin | 3.6% | 4.2% |
| ROE | 12.6% | 36.5% |
| ROIC | 9.3% | 19.9% |
| 1y total return | +41.5% | +70.0% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: ELV vs UNH
| Metric | ELV | UNH |
|---|---|---|
| End value | $31.4K | $37.7K |
| Total return | +214.1% | +276.7% |
| CAGR | +11.7% | +13.7% |
| Volatility | 31.0% | 29.9% |
| Sharpe | 0.39 | 0.45 |
| Sortino | 0.55 | 0.62 |
| Max drawdown | -50.4% | -61.4% |
Based on 2600 common trading days, 2016-04-06 → 2026-08-07 · risk-free 3.87% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)